GlassScriptPhysician profile
Vicente Quintero
NPI 1114978624
$12,076.73
in general payments reported to CMS, 2019-2025
42 companies · $2,967 in 2025
The $2,967 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2020: $694 · 2021: $948 · 2022: $1,549 · 2023: $2,235 · 2024: $2,534 · 2025: $2,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,393 · Education: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,393.44 |
| Education | $342.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,393.40 | 2019-2025 | |
| Janssen Biotech, INC. | $1,144.89 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Lilly USA, LLC | $1,050.29 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $962.99 | 2019-2025 | Bimzelx, Cimzia |
| Amgen INC. | $916.65 | 2021-2025 | Otezla, Repatha, Otezla |
| Regeneron Healthcare Solutions, INC. | $766.95 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $672.66 | 2019-2025 | |
| Incyte Corporation | $472.03 | 2022-2025 | Opzelura |
| Genzyme Corporation | $464.07 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $447.16 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $415.69 | 2019-2025 | Nemluvio, Aklief, Twyneo |
| Arcutis Biotherapeutics, INC. | $301.35 | 2023-2025 | Zoryve |
| Pfizer INC. | $291.47 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $239.97 | 2019-2025 | Ilumya, Blu-U, Odomzo |
| Abbott Laboratories | $235.41 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicente Quintero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.